PHASTAR

PHASTAR

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $20M

Overview

PHASTAR is an award-winning, specialist biometrics CRO that leverages deep statistical expertise and innovative technology to support clinical development programs from design through regulatory submission. The company differentiates itself through a 'right first-time' delivery approach, a flexible and scalable service model, and a strong track record in trial rescue and quality assurance. With over 400 specialists across 15 countries, PHASTAR partners with sponsors to optimize data strategy, mitigate risk, and accelerate the path of new therapies to patients.

BiostatisticsClinical Research

Technology Platform

Proprietary framework and Clinical Intelligence Portal for clinical data analysis, featuring AI-enhanced analytics, advanced statistical methods, and tools like a Recruitment Forecasting app to optimize trial delivery and data packaging for regulatory submission.

Funding History

2
Total raised:$20M
Series B$15M
Series A$5M

Opportunities

Growth is driven by increasing clinical trial complexity, rising demand for specialized biometrics outsourcing, and the adoption of advanced analytics and AI in drug development.
Expansion into new geographic markets and deeper strategic FSP partnerships present significant avenues for scaling the business.

Risk Factors

Key risks include dependence on pharmaceutical R&D spending cycles, intense competition from both large full-service and niche CROs, and the critical challenge of attracting and retaining scarce, high-caliber statistical and data science talent in a competitive market.

Competitive Landscape

PHASTAR competes in the specialist biometrics segment against other niche CROs like Cytel and Quanticate, as well as the large biometrics divisions of full-service CRO giants (e.g., IQVIA, Labcorp, Parexel). Its differentiation hinges on a focused 'right first-time' quality ethos, flexible service models, and a strong reputation in trial rescue.